Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RPL7L1 pseudogene 15** is a human pseudogene derived from the ribosomal protein L7 like 1 (RPL7L1) gene[8][9]. Pseudogenes typically arise from duplication or retrotransposition events and do not encode functional proteins. RPL7L1P15 is listed in gene nomenclature databases as a pseudogene with no known function, no protein product, and no confirmed role in disease or therapy[8][9][5]. For clarification, the **RPL7L1** gene (not the pseudogene) encodes a ribosomal protein with roles in ribosome structure and function, and has emerging evidence of involvement in certain cancers[2][7]. However, **RPL7L1P15** is a noncoding, non-functional genomic segment. In summary: RPL7L1P15 is a pseudogene, not a therapeutic target, has no aliases or functions relevant to drug discovery, and should not be considered for further therapeutic or biomarker research.
None. No mechanism of action applies due to the lack of a functional product
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RPL7L1 pseudogene 15 (RPL7L1P15).